Inflation cooled further in May in a big sigh of relief to investors and the Federal Reserve. The personal consumption expenditure (PCE) price index, the Federal Reserve’s preferred inflation gauge, held steady sequentially in May after increasing 0.3% in April. On a year-over-year basis, the PCE index climbed 2.6% in May after rising 2.7% in the prior month. Core PCE, which strips out the volatile food and energy components, increased marginally by 0.1% sequentially in May following an upwardly revised 0.3% increase in April. Year over year, core PCE increased 2.6% in May after rising 2.8% in April. Inflation declined sharply in 2023 after the Federal Reserve hiked interest rates by 525 basis points since March 2022 to curb 40-year-high inflation. This raised hopes at the beginning of 2024 that the Fed would soon go ahead with multiple rate cuts. The optimism faded soon as inflation resumed its climb, increasing sharply in the first quarter. However, it finally started showing signs of cooling in April, which has once again made investors optimistic. Also, Federal Reserve Chairman Jerome Powell, in his June post-FOMC statement, indicated that the rate hike regime is likely over and the central bank is planning one 25 basis point rate cut this year. However, markets are pricing in two rate cuts in 2024 after the positive May inflation data, with the first rate cut likely to be effected in September. Lower rate cuts bode well for the broader economy. 3 Best Choices We have, thus, selected three large-cap mutual funds such as Fidelity Series Blue Chip Growth Fund FSBDX, Fidelity Blue Chip Growth K6 FBCGX and Janus Henderson Research A JRAAX, carrying a Zacks Mutual Fund Rank #1 (Strong Buy) or 2 (Buy), that are poised to gain from such factors. Moreover, these funds have encouraging three and five-year returns. The minimum initial investment is within $5000. We expect these funds to outperform their peers in the future. Remember, the goal of the Zacks Mutual Fund Rank is to guide investors in identifying potential winners and losers. Unlike most of the fund-rating systems, the Zacks Mutual Fund Rank is not just focused on past performance but also on the likely future success of the fund. The question here is: why should investors consider mutual funds? Reduced transaction costs and diversification of portfolio without several commission charges that are associated with stock purchases are primarily why one should be parking money in mutual funds (read more: Mutual Funds: Advantages, Disadvantages, and How They Make Investors Money). Fidelity Series Blue Chip Growth Fund invests in common stocks of blue-chip companies that generally have large or medium-market capitalizations. FSBDX is non-diversified. Fidelity Series Blue Chip Growth Fund (has a track of positive total returns for over 10 years. Specifically, FSBDX’s returns over the three and five-year benchmarks are 10.4% and 23%, respectively. FSBDX has a Zacks Mutual Fund Rank #1 and an annual expense ratio of 0.01%. To see how this fund performed compared to its category, and other #1 or 2 Ranked Mutual Funds, please click here. Fidelity Blue Chip Growth K6 fund invests most of its net assets in common stocks of blue-chip companies, according to Fidelity Management & Research Company LLC. FBCGX advisors generally choose to invest in large or medium market-capitalization companies. Fidelity Blue Chip Growth K6 fund has a track of positive total returns for over 10 years. Specifically, FBCGX’s returns over the three and five-year benchmarks are 9.6% and 22.8%, respectively. FBCGX has an annual expense ratio of 0.45% and a Zacks Mutual Fund Rank #1. To see how this fund performed compared to its category, and other #1 or 2 Ranked Mutual Funds, please click here. Janus Henderson Research A fund is part of the Large Cap Growth mutual fund category. JRAAX invests in many large U.S. companies that are expected to grow much faster than the other large-cap stocks. Janus Henderson Research A fund has had a track of positive total returns for over 10 years. Specifically, JRAAX’s returns over the three and five-year benchmarks are 9.8% and 16.9%, respectively. The fund’s annual expense ratio is 0.81%. JRAAX has a Zacks Mutual Fund Rank #1. To see how this fund performed compared to its category, and other #1 or 2 Ranked Mutual Funds, please click here. Want key mutual fund info delivered straight to your inbox? Zacks' free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Get Your Free (JRAAX): Fund Analysis Report Get Your Free (FSBDX): Fund Analysis Report Get Your Free (FBCGX): Fund Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
3 Large-Cap Growth Funds to Buy as Inflation Eases in May
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...